Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

50.650
+0.1500.30%
Volume:33.03M
Turnover:1.68B
Market Cap:209.94B
PE:37.45
High:52.000
Open:50.500
Low:50.100
Close:50.500
52wk High:54.450
52wk Low:28.480
Shares:4.15B
HK Float Shares:4.15B
Volume Ratio:0.59
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.353
ROE:11.38%
ROA:7.60%
PB:3.75
PE(LYR):37.45
PS:7.63

Loading ...

WuXi Biologics H1 Net Income Attributable RMB 2,439.8 Million

THOMSON REUTERS
·
Aug 25

Wuxi Biologics (Cayman) Stock Rallies 7.4% in Hong Kong

Dow Jones
·
Aug 25

HK-Listed WuXi XDC Hits 10-Month Peak on Solid First-Half Results

Reuters
·
Aug 25

Hong Kong Stocks in Focus: CRO Sector Rallies as Offshore CXO Leaders Post Strong Results

Stock News
·
Aug 25

Movement Alert|WUXI BIO Rises 3.81% in Regular Trading, Interim Results Review Coincides with CXO Sector Broad Rally

Market Focus
·
Aug 25

Transcenta Holding Announces Extraordinary General Meeting

Reuters
·
Aug 25

Chinese Drugmaker Wuxi XDC's First-Half Revenue Rises on Project Expansion, Acquisition

Reuters
·
Aug 24

WuXi XDC FY26 H1 Net Profit Rises 9.7% to RMB 818 Million; Revenue Climbs 37% to RMB 3.7 Billion

Reuters
·
Aug 24

Wuxi Biologics (Cayman) Stock Falls 4.7% in Hong Kong

Dow Jones
·
Aug 24

Movement Alert|WUXI BIO Falls 3.33% in Regular Trading, CXO Sector Pullback and Pre-Earnings Profit-Taking Weigh on Shares

Market Focus
·
Aug 24

TOT Biopharm FY26 H1 Net Loss Swings to RMB 59 Million; Revenue Drops 49.7% to RMB 246 Million

Reuters
·
Aug 21

Wuxi Biologics (Cayman) Stock Rallies 2.7% in Hong Kong

Dow Jones
·
Aug 21

Movement Alert|WUXI BIO Rises 6.16% in Regular Trading, Interim Results Review Imminent Amid CXO Sector Rally

Market Focus
·
Aug 20

Biotech Sector Surges as Moderna's Melanoma Vaccine Milestone Sparks Oncology and mRNA Repricing

Stock News
·
Aug 20

Wuxi Biologics (Cayman) Stock Falls 1.4% in Hong Kong

Dow Jones
·
Aug 19

Global Food Inflation Risks Return While Robotics Stocks Rally on Yushu Tech's Upcoming Debut

Stock News
·
Aug 18

WuXi Biologics Wins BioPharma APAC Spot on 2026 Sustainable Biopharma List

Reuters
·
Aug 18

WuXi XDC Secures GMP Release for BCM3 Bioconjugate Production Line in Singapore

Reuters
·
Aug 18

HK Movers | Pharma Stocks Rally With Genscript Biotech up 6%, WuXi Biologics up 5%

Tiger Newspress
·
Aug 18

Movement Alert|WUXI BIO Rises 3.38% in Regular Trading, CXO Sector Momentum Sustained as Interim Results Approach

Market Focus
·
Aug 18